United States · FDA National Drug Code directory
Glipizide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2520_687074dd-3947-4d61-bad3-7857f2c67a53
- Product NDC
- 71335-2520
- Form
- TABLET
- Composition / generic term
- Glipizide
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220531
- Source listing expiry
- 20271231
Source-listed ingredients
- GLIPIZIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (71335-2520-1) · 71335-2520-1
- 30 TABLET in 1 BOTTLE (71335-2520-2) · 71335-2520-2
- 60 TABLET in 1 BOTTLE (71335-2520-3) · 71335-2520-3
- 90 TABLET in 1 BOTTLE (71335-2520-4) · 71335-2520-4
- 20 TABLET in 1 BOTTLE (71335-2520-5) · 71335-2520-5
- 180 TABLET in 1 BOTTLE (71335-2520-6) · 71335-2520-6
- 10 TABLET in 1 BOTTLE (71335-2520-7) · 71335-2520-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →